However, these “legacy” sterilization methods are not as effective with newer, more complex products, especially those with advanced materials or biologics. Longer lead times for the packaging development requirements for these devices must also be considered; new packaging formats or materials typically require extensive validation testing, which must be factored into the launch timeline.
Many medical device manufacturers (MDMs) are reluctant to embrace new methods of sterilization and packaging unless a strong business case exists for working outside of tried-and-tested solutions. And, even though they know it is ultimately in their best interests to move forward with new technologies, some still try to make the old ones work—mostly to save money and hasten speed to market.
This approach, however, can easily backfire.
“Medical devi
Continue reading this story and get 24/7 access to Medical Product Outsourcing for FREE
Our in-depth coverage includes comprehensive feature articles, industry news, trends, and other developments pertinent to the service provider-OEM relationship. MPO examines the increasingly complex and demanding requirements of managing outsourcing partnerships. From regulatory mandates and manufacturing best practices to market shifts and legal concerns, our website is filled with exclusive content to help device manufacturers and their vendors stay informed. Join Today!
FREE SUBSCRIPTION